Lyell Immunopharma Inc (LYEL)
2.36
-0.04
(-1.67%)
USD |
NASDAQ |
May 03, 16:00
2.36
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Market Cap: 599.67M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 599.67M |
| May 02, 2024 | 609.83M |
| May 01, 2024 | 592.04M |
| April 30, 2024 | 551.39M |
| April 29, 2024 | 571.72M |
| April 26, 2024 | 551.39M |
| April 25, 2024 | 559.01M |
| April 24, 2024 | 584.42M |
| April 23, 2024 | 620.00M |
| April 22, 2024 | 612.37M |
| April 19, 2024 | 566.63M |
| April 18, 2024 | 592.04M |
| April 17, 2024 | 604.75M |
| April 16, 2024 | 612.37M |
| April 15, 2024 | 609.83M |
| April 12, 2024 | 764.83M |
| April 11, 2024 | 675.90M |
| April 10, 2024 | 622.54M |
| April 09, 2024 | 640.32M |
| April 08, 2024 | 556.47M |
| April 05, 2024 | 531.06M |
| April 04, 2024 | 531.06M |
| April 03, 2024 | 523.44M |
| April 02, 2024 | 528.52M |
| April 01, 2024 | 553.93M |
| Date | Value |
|---|---|
| March 28, 2024 | 566.63M |
| March 27, 2024 | 518.36M |
| March 26, 2024 | 492.95M |
| March 25, 2024 | 487.86M |
| March 22, 2024 | 487.86M |
| March 21, 2024 | 518.36M |
| March 20, 2024 | 517.09M |
| March 19, 2024 | 505.65M |
| March 18, 2024 | 528.52M |
| March 15, 2024 | 548.85M |
| March 14, 2024 | 561.55M |
| March 13, 2024 | 597.13M |
| March 12, 2024 | 553.93M |
| March 11, 2024 | 592.04M |
| March 08, 2024 | 637.78M |
| March 07, 2024 | 640.32M |
| March 06, 2024 | 670.81M |
| March 05, 2024 | 637.78M |
| March 04, 2024 | 661.92M |
| March 01, 2024 | 780.08M |
| February 29, 2024 | 741.96M |
| February 28, 2024 | 721.63M |
| February 27, 2024 | 724.17M |
| February 26, 2024 | 665.73M |
| February 23, 2024 | 607.29M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
350.10M
Minimum
Oct 04 2023
4.297B
Maximum
Sep 10 2021
1.370B
Average
1.007B
Median
May 26 2022
Market Cap Benchmarks
| GlycoMimetics Inc | 117.94M |
| Candel Therapeutics Inc | 264.71M |
| Eliem Therapeutics Inc | 281.49M |
| Entrada Therapeutics Inc | 442.19M |
| NovaBay Pharmaceuticals Inc | 2.856M |
Market Cap Related Metrics
| PS Ratio | 4556.23 |
| PEG Ratio | -0.0988 |
| Price to Book Value | 0.9156 |
| Price | 2.36 |
| Earnings Yield | -39.41% |
| PEGY Ratio | -0.0988 |